Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 82009-074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 82009-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Olmesartan Fig1)

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Olmesartan Fig1)
A dose-response line graph depicting the placebo-adjusted reduction in blood pressure (mmHg) by Olmesartan Medoxomil dose (mg). The graph shows two curves: one for systolic blood pressure reduction and one for diastolic blood pressure reduction, both increasing as dose increases up to about 40 mg, with the systolic reduction plateauing around 12.5 mmHg and diastolic around 7.5 mmHg.*
FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 5 mg film-coated tablets, packaged with 90 tablets. Manufactured by Aurobindo Pharma Limited, India, and labeled for Quallent Pharmaceuticals Health LLC. Includes storage instructions, Rx only designation, and NDC 82009-073-90 with barcode.*
FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablet Bottle))

Package Label-principal Display Panel (20 mg (30 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 20 mg, film-coated tablets. The package contains 90 tablets with NDC 82009-074-90. It is manufactured by Aurobindo Pharma Limited in India and labeled for Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. The label includes storage instructions and dosage strength.*
FDA Label Image

Package Label-principal Display Panel (40 mg (90 Tablet Bottle))

Package Label-principal Display Panel (40 mg (90 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 40 mg film-coated tablets. The package contains 90 tablets and is labeled for prescription use only. Manufactured by Aurobindo Pharma Limited, India, for Quallent Pharmaceuticals Health LLC, Grand Cayman. The label includes storage instructions and a barcode.*
FDA Label Image

Chemical Structure (Olmesartan Str)

Chemical Structure (Olmesartan Str)
Chemical structure of Olmesartan Medoxomil showing its molecular composition with rings and functional groups as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.